193 related articles for article (PubMed ID: 23338231)
1. Hair mass index obtained by cross-section trichometry: an objective and clinically useful parameter to quantify hair in chemotherapy-induced alopecia.
Vleut RE; van Poppel JE; Dercksen MW; Peerbooms M; Houterman S; Breed WP
Support Care Cancer; 2013 Jul; 21(7):1807-14. PubMed ID: 23338231
[TBL] [Abstract][Full Text] [Related]
2. Patient-reported outcome assessment and objective evaluation of chemotherapy-induced alopecia.
Komen MMC; van den Hurk CJG; Nortier JWR; van der Ploeg T; Smorenburg CH; van der Hoeven JJM
Eur J Oncol Nurs; 2018 Apr; 33():49-55. PubMed ID: 29551177
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
Cigler T; Isseroff D; Fiederlein B; Schneider S; Chuang E; Vahdat L; Moore A
Clin Breast Cancer; 2015 Oct; 15(5):332-4. PubMed ID: 25749072
[TBL] [Abstract][Full Text] [Related]
4. Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer.
van den Hurk CJ; van den Akker-van Marle ME; Breed WP; van de Poll-Franse LV; Nortier JW; Coebergh JW
Eur J Oncol Nurs; 2013 Oct; 17(5):536-40. PubMed ID: 23571182
[TBL] [Abstract][Full Text] [Related]
5. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
Nangia J; Wang T; Osborne C; Niravath P; Otte K; Papish S; Holmes F; Abraham J; Lacouture M; Courtright J; Paxman R; Rude M; Hilsenbeck S; Osborne CK; Rimawi M
JAMA; 2017 Feb; 317(6):596-605. PubMed ID: 28196254
[TBL] [Abstract][Full Text] [Related]
6. Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.
Komen MMC; van den Hurk CJG; Nortier JWR; van der Ploeg T; Nieboer P; van der Hoeven JJM; Smorenburg CH
Support Care Cancer; 2019 May; 27(5):1919-1925. PubMed ID: 30206728
[TBL] [Abstract][Full Text] [Related]
7. COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer.
Smetanay K; Junio P; Feißt M; Seitz J; Hassel JC; Mayer L; Matthies LM; Schumann A; Hennigs A; Heil J; Sohn C; Jaeger D; Schneeweiss A; Marmé F
Breast Cancer Res Treat; 2019 Jan; 173(1):135-143. PubMed ID: 30255454
[TBL] [Abstract][Full Text] [Related]
8. A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention.
Dunnill CJ; Al-Tameemi W; Collett A; Haslam IS; Georgopoulos NT
Oncologist; 2018 Jan; 23(1):84-96. PubMed ID: 28951499
[TBL] [Abstract][Full Text] [Related]
9. Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy.
Ohsumi S; Kiyoto S; Takahashi M; Hara F; Takashima S; Aogi K; Matsuda M; Yamamura N; Doi M
Support Care Cancer; 2021 Jan; 29(1):437-443. PubMed ID: 32388615
[TBL] [Abstract][Full Text] [Related]
10. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
Rugo HS; Klein P; Melin SA; Hurvitz SA; Melisko ME; Moore A; Park G; Mitchel J; Bågeman E; D'Agostino RB; Ver Hoeve ES; Esserman L; Cigler T
JAMA; 2017 Feb; 317(6):606-614. PubMed ID: 28196257
[TBL] [Abstract][Full Text] [Related]
11. Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia.
Komen MM; Breed WP; Smorenburg CH; van der Ploeg T; Goey SH; van der Hoeven JJ; Nortier JW; van den Hurk CJ
Support Care Cancer; 2016 Jun; 24(6):2735-41. PubMed ID: 26805558
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of hair recovery after (neo)adjuvant chemotherapy with scalp cooling in Japanese breast cancer patients.
Ohsumi S; Kiyoto S; Takahashi M; Takashima S; Aogi K; Shimizu S; Doi M
Support Care Cancer; 2021 Oct; 29(10):6119-6125. PubMed ID: 33797582
[TBL] [Abstract][Full Text] [Related]
13. Minimal added value of wetting hair before scalp cooling to prevent chemotherapy-induced alopecia in cancer patients - results from the Dutch Scalp Cooling Registry.
Heibloem RE; Komen MMC; Ilozumba OUC; van den Hurk CJG
Support Care Cancer; 2023 Apr; 31(5):273. PubMed ID: 37067605
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of penguin cap as scalp cooling system for prevention of alopecia in patients undergoing chemotherapy.
Kargar M; Sarvestani RS; Khojasteh HN; Heidari MT
J Adv Nurs; 2011 Nov; 67(11):2473-7. PubMed ID: 21635283
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment.
Betticher DC; Delmore G; Breitenstein U; Anchisi S; Zimmerli-Schwab B; Müller A; von Moos R; Hügli-Dayer AM; Schefer H; Bodenmann S; Bühler V; Trueb RR
Support Care Cancer; 2013 Sep; 21(9):2565-73. PubMed ID: 23636645
[TBL] [Abstract][Full Text] [Related]
16. Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy.
Rice BA; Ver Hoeve ES; DeLuca AN; Esserman LJ; Rugo HS; Melisko ME
Breast Cancer Res Treat; 2018 Jan; 167(1):117-122. PubMed ID: 28921303
[TBL] [Abstract][Full Text] [Related]
17. Scalp hypothermia in the prevention of chemotherapy-induced alopecia.
Vendelbo Johansen L
Acta Radiol Oncol; 1985; 24(2):113-6. PubMed ID: 2988271
[TBL] [Abstract][Full Text] [Related]
18. Cross-section Trichometry: A Clinical Tool for Assessing the Progression and Treatment Response of Alopecia.
Wikramanayake TC; Mauro LM; Tabas IA; Chen AL; Llanes IC; Jimenez JJ
Int J Trichology; 2012 Oct; 4(4):259-64. PubMed ID: 23766610
[TBL] [Abstract][Full Text] [Related]
19. Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients.
Ridderheim M; Bjurberg M; Gustavsson A
Support Care Cancer; 2003 Jun; 11(6):371-7. PubMed ID: 12768403
[TBL] [Abstract][Full Text] [Related]
20. Comparable effectiveness of 45- and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia - a randomized controlled trial.
Lugtenberg RT; van den Hurk CJG; Smorenburg CH; Mosch L; Houtsma D; Deursen MAGDH; Kaptein AA; Gelderblom H; Kroep JR
Support Care Cancer; 2022 Aug; 30(8):6641-6648. PubMed ID: 35501515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
